Uncovering the next great stocks: American Express Company (AXP), Spectrum Pharmaceuticals, Inc. (SPPI)

The shares of American Express Company have increased by more than 23.07% this year alone. The shares recently went down by -2.18% or -$2.61 and now trades at $117.31. The shares of Spectrum Pharmaceuticals, Inc. (NASDAQ:SPPI), has jumped by 1.37% year to date as of 09/10/2019. The shares currently trade at $8.87 and have been able to report a change of 26.17% over the past one week.

The stock of American Express Company and Spectrum Pharmaceuticals, Inc. were two of the most active stocks on Tuesday. Investors seem to be very interested in what happens to the stocks of these two companies but do investors favor one over the other? We will analyze the growth, profitability, risk, valuation, and insider trends of both companies and see which one investors prefer.

Profitability and Returns

Growth alone cannot be used to see if the company will be valuable. Shareholders will be the losers if a company invest in ventures that aren’t profitable enough to support upbeat growth. In order for us to accurately measure profitability and return, we will be using the EBITDA margin and Return on Investment (ROI), which balances the difference in capital structure. AXP has an EBITDA margin of 14.25%, this implies that the underlying business of AXP is more profitable. The ROI of AXP is 4.20% while that of SPPI is -46.30%. These figures suggest that AXP ventures generate a higher ROI than that of SPPI.

Cash Flow

The value of a stock is ultimately determined by the amount of cash flow that the investors have available. Over the last 12 months, AXP’s free cash flow per share is a positive 4.87, while that of SPPI is negative -0.04.

Liquidity and Financial Risk

The ability of a company to meet up with its short-term obligations and be able to clear its longer-term debts is measured using Liquidity and leverage ratios. The debt ratio of AXP is 5.77 compared to 0.00 for SPPI. AXP can be able to settle its long-term debts and thus is a lower financial risk than SPPI.


AXP currently trades at a forward P/E of 13.05, a P/B of 4.24, and a P/S of 2.25 while SPPI trades at a P/B of 3.84, and a P/S of 18.25. This means that looking at the earnings, book values and sales basis, AXP is the cheaper one. It is very obvious that earnings are the most important factors to investors, thus analysts are most likely to place their bet on the P/E.

Analyst Price Targets and Opinions

The mistake some people make is that they think a cheap stock has more value to it. In order to know the value of a stock, there is need to compare its current price to its likely trading price in the future. The price of AXP is currently at a -11.53% to its one-year price target of 132.60. Looking at its rival pricing, SPPI is at a -61.77% relative to its price target of 23.20.

When looking at the investment recommendation on say a scale of 1 to 5 (1 being a strong buy, 3 a hold, and 5 a sell), AXP is given a 2.40 while 1.60 placed for SPPI. This means that analysts are more bullish on the outlook for AXP stocks.

Insider Activity and Investor Sentiment

Short interest or otherwise called the percentage of a stock’s tradable shares currently being shorted is another data that investors use to get a handle on sentiment. The short ratio for AXP is 1.89 while that of SPPI is just 13.44. This means that analysts are more bullish on the forecast for AXP stock.


The stock of Spectrum Pharmaceuticals, Inc. defeats that of American Express Company when the two are compared, with SPPI taking 6 out of the total factors that were been considered. SPPI happens to be more profitable, generates a higher ROI, has higher cash flow per share, higher liquidity and has a lower financial risk. When looking at the stock valuation, SPPI is the cheaper one on an earnings, book value and sales basis. Finally, the sentiment signal for SPPI is better on when it is viewed on short interest.